Suchen Sie nach Informationen zu Hospira Europa-Zentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.ema.europa.eu/en/medicines/human/EPAR/levetiracetam-hospira
The active substance in Levetiracetam Hospira, levetiracetam, is an epilepsy medicine. Epilepsy is caused by excessive electrical activity in the brain. The exact way in which levetiracetam works is still unclear but it attaches to a protein called synaptic vesicle protein 2A, which is involved in the release of chemical messengers from nerve ...
https://en.wikipedia.org/wiki/Hospira
https://www.ema.europa.eu/en/medicines/human/EPAR/daptomycin-hospira
Daptomycin Hospira is given into a vein as an infusion lasting 30 minutes or as an injection lasting 2 minutes. In children, the dose of Daptomycin Hospira for skin or soft tissue infection without bacteraemia depends on the child’s age and ranges between 5 and 10 mg/kg body weight once a day. Higher doses (between 7 and 12 mg/kg once a day ...
https://www.ema.europa.eu/en/medicines/human/EPAR/zoledronic-acid-hospira
Zoledronic Acid Hospira is a medicine that contains the active substance zoledronic acid. It is available as a concentrate (4 mg/5 ml) to be made up into a solution for infusion (drip) into a vein, and as solutions for infusion (4 mg/100 ml and 5 mg/100 ml). Zoledronic Acid Hospira is a ‘generic’ and a ‘hybrid’ medicine.
https://www.ema.europa.eu/en/medicines/human/EPAR/pemetrexed-hospira
The active substance in Pemetrexed Hospira, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’. In the body, pemetrexed is converted into an active form that blocks the activity of the enzymes that are involved in producing ‘nucleotides ...
https://www.ema.europa.eu/en/medicines/human/referrals/teicoplanin-hospira
Teicoplanin Hospira is an antibiotic. It is use to treat patients with serious infections due to Gram-positive bacteria. Gram-positive bacteria include bacteria such as staphylocci (Staphylococcus aureus), streptococci (Streptococcus pneumoniae), Listeria, Clostridium difficile.These bacteria can cause skin infections, lung infections, joint and bone infections, heart infections or …
https://www.ema.europa.eu/en/medicines/human/EPAR/topotecan-hospira
Topotecan Hospira is a concentrate that is made up into a solution for infusion (drip into a vein). It contains the active substance topotecan. Topotecan Hospira is a ‘ hybrid medicine ’. This means that Topotecan Hospira is similar to a ‘reference medicine’ already authorised in the European Union (EU). The reference medicine Hycamtin ...
https://www.ema.europa.eu/en/medicines/human/EPAR/palonosetron-hospira
Therapeutic indication. Palonosetron Hospira is indicated in adults for: the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy; the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. Palonosetron Hospira is indicated in paediatric patients 1 month of age …
https://www.dnb.com/business-directory/company-profiles.hospira_zagreb_doo.10d490d1c4b262dd4092e48a6537a91f.html
Company Description: Hospira Zagreb d.o.o. is located in Prudnice, Zagrebacka zupanija, Croatia and is part of the Pharmaceutical and Medicine Manufacturing Industry. Hospira Zagreb d.o.o. has 368 employees at this location and generates $105.41 million in sales (USD). There are 222 companies in the Hospira Zagreb d.o.o. corporate family.
https://www.bloomberg.com/profile/company/0160747D:GR
Company profile page for Hospira Deutschland GmbH including stock price, company news, press releases, executives, board members, and contact information
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hospira Europa-Zentrale gefunden haben.
